249 related articles for article (PubMed ID: 25847065)
21. Exendin-4 regulates GLUT2 expression via the CaMKK/CaMKIV pathway in a pancreatic β-cell line.
Chen K; Yu X; Murao K; Imachi H; Li J; Muraoka T; Masugata H; Zhang GX; Kobayashi R; Ishida T; Tokumitsu H
Metabolism; 2011 Apr; 60(4):579-85. PubMed ID: 20598720
[TBL] [Abstract][Full Text] [Related]
22. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins.
Langendorf CG; O'Brien MT; Ngoei KRW; McAloon LM; Dhagat U; Hoque A; Ling NXY; Dite TA; Galic S; Loh K; Parker MW; Oakhill JS; Kemp BE; Scott JW
J Biol Chem; 2020 Nov; 295(48):16239-16250. PubMed ID: 32913128
[TBL] [Abstract][Full Text] [Related]
23. Calcium/calmodulin-dependent protein kinase IV (CaMKIV) enhances osteoclast differentiation via the up-regulation of Notch1 protein stability.
Choi YH; Ann EJ; Yoon JH; Mo JS; Kim MY; Park HS
Biochim Biophys Acta; 2013 Jan; 1833(1):69-79. PubMed ID: 23103515
[TBL] [Abstract][Full Text] [Related]
24. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of an R311C variant of Ca
Xy Ling N; Langendorf CG; Hoque A; Galic S; Loh K; Kemp BE; Gundlach AL; Oakhill JS; Scott JW
Bipolar Disord; 2020 Dec; 22(8):841-848. PubMed ID: 32216002
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.
Fu H; He HC; Han ZD; Wan YP; Luo HW; Huang YQ; Cai C; Liang YX; Dai QS; Jiang FN; Zhong WD
Tumour Biol; 2015 Mar; 36(3):1983-91. PubMed ID: 25394900
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of basal transcriptional activity of the cytochrome P450 cholesterol side-chain cleavage (CYP11A) gene by isoform-specific calcium-calmodulin-dependent protein kinase in primary cultures of ovarian granulosa cells.
Seals RC; Urban RJ; Sekar N; Veldhuis JD
Endocrinology; 2004 Dec; 145(12):5616-22. PubMed ID: 15319355
[TBL] [Abstract][Full Text] [Related]
28. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Distinct Roles of CaMKK Isoforms Using STO-609-Resistant Mutants in Living Cells.
Fujiwara Y; Hiraoka Y; Fujimoto T; Kanayama N; Magari M; Tokumitsu H
Biochemistry; 2015 Jun; 54(25):3969-77. PubMed ID: 26050738
[TBL] [Abstract][Full Text] [Related]
30. A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells.
Monaco S; Rusciano MR; Maione AS; Soprano M; Gomathinayagam R; Todd LR; Campiglia P; Salzano S; Pastore L; Leggiero E; Wilkerson DC; Rocco M; Selleri C; Iaccarino G; Sankar U; Illario M
Cell Signal; 2015 Feb; 27(2):204-14. PubMed ID: 25446257
[TBL] [Abstract][Full Text] [Related]
31. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
32. Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells.
Huang W; Liu Y; Luz A; Berrong M; Meyer JN; Zou Y; Swann E; Sundaramoorthy P; Kang Y; Jauhari S; Lento W; Chao N; Racioppi L
Front Immunol; 2021; 12():754083. PubMed ID: 34712241
[TBL] [Abstract][Full Text] [Related]
33. Calcium/calmodulin-dependent protein kinase kinase 2 regulates hepatic fuel metabolism.
Stork BA; Dean A; Ortiz AR; Saha P; Putluri N; Planas-Silva MD; Mahmud I; Rajapakshe K; Coarfa C; Knapp S; Lorenzi PL; Kemp BE; Turk BE; Scott JW; Means AR; York B
Mol Metab; 2022 Aug; 62():101513. PubMed ID: 35562082
[TBL] [Abstract][Full Text] [Related]
34. Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8.
Lee EK; Kim DG; Kim JS; Yoon Y
Cancer Res; 2011 Nov; 71(21):6827-35. PubMed ID: 21917729
[TBL] [Abstract][Full Text] [Related]
35. Regulation and properties of the rat Ca2+/calmodulin-dependent protein kinase IV gene and its protein products.
Means AR; Ribar TJ; Kane CD; Hook SS; Anderson KA
Recent Prog Horm Res; 1997; 52():389-406; discussion 406-7. PubMed ID: 9238860
[TBL] [Abstract][Full Text] [Related]
36. The Ca
Jianfei L; Min W; Chunlai M; Bicui C; Jiming Z; Bin W
Biochem Pharmacol; 2017 Dec; 146():224-232. PubMed ID: 29038020
[TBL] [Abstract][Full Text] [Related]
37. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
[TBL] [Abstract][Full Text] [Related]
38. The Ca(2+)/Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft.
Marcelo KL; Means AR; York B
Trends Endocrinol Metab; 2016 Oct; 27(10):706-718. PubMed ID: 27449752
[TBL] [Abstract][Full Text] [Related]
39. RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway.
Wang S; Huang X; Li Y; Lao H; Zhang Y; Dong H; Xu W; Li JL; Li M
Hepatology; 2011 Jun; 53(6):1932-42. PubMed ID: 21391225
[TBL] [Abstract][Full Text] [Related]
40. Systemic Ablation of
Pulliam TL; Awad D; Han JJ; Murray MM; Ackroyd JJ; Goli P; Oakhill JS; Scott JW; Ittmann MM; Frigo DE
Cells; 2022 Jun; 11(12):. PubMed ID: 35741020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
